source
- Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvalsThe FDA is currently reviewing Vertex Pharmaceuticals’ povetacicept, with a target action date of Nov. 30. If approved, the drug could benefit from campaigns from Novartis and Vera Therapeutics for…BioSpace · 11d ago↗ source
- STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputerBristol Myers Squibb is the third drugmaker in nine months to announce it is building the largest AI supercomputer in the life sciences industry.STAT · 11d ago↗ source
- Opinion: My husband’s suicide shows there’s something very wrong with the U.S. insurance industry“My love for Randy and my professional experience were not enough to save him,” a physician writes about her husband’s suicide.